https://orcid.org/0000-0002-5044-0069
References
- Mirowski M, Reid PR, and Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322–324.
- DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med. 2003 Nov 6;349(19):1836–1847. PMID: 14602883.
- Wellens HJ, Schwartz PJ, Lindemans FW, et al. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014 Jul 1;35(25):1642–1651.
- Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: cardiovascular disease statistics 2019. Eur Heart J. 2020 Jan 1;41(1):12–85.
- Vergara P, Pignalberi C, Pisanò EC, et al. Circadian periodicity affects the type of ventricular arrhythmias and efficacy of implantable defibrillator therapies. J Cardiovasc Electrophysiol. 2021;32:2528–2535.
- van Welsenes GH, van Rees JB, Borleffs CJ, et al. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace. 2011;13:389–394.
- Oseroff O, Retyk E, Bochoeyer A. Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH). Curr Opin Cardiol. 2004;19:26–30.
- Bardy GH, Lee KL, and Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237.
- Moss AJ, Hall WJ, and Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 1996;335:1933–1940.
- Køber L, Thune JJ, and Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221–1230.
- Guaricci AI, Pontone G, and Gaibazzi N, et al. Primary prevention implantable cardioverter–defibrillator therapy: a matter not yet adequately explored waiting for guidelines update. ESC Heart Fail. 2017;4:487–489.
- O’Mahony C, Jichi F, Pavlou M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014 Aug 7;35(30):2010–2020.
- Elliott PM, Anastasakis A, Borger MA, et al. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014 Oct 14;35(39):2733–2779.
- Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2019 Jun 14;40(23):1850–1858. PMID: 30915475; PMCID: PMC6568197.
- Kristensen SL, Levy WC, and Shadman R, et al. Risk models for prediction of implantable cardioverter-defibrillator benefit: insights from the DANISH trial. JACC Heart Fail. 2019;7:717–724.
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021 Sept 21;42(36):3599–3726.
- Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society originally published 1 Aug 2018. Circulation. 2018;138:e272–e391.
- Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Eur Heart J. 2015 Nov 1;36(41):2793–2867.
- cited 2020 Jan 25. Available from: www.clinicaltrials.gov
- Gasperetti A, Schiavone M, Ziacchi M, et al. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: real-world data from the extended ELISIR experience. Heart Rhythm. 2021 Dec;18(12):2050–2058.
- Mitacchione G, Schiavone M, Gasperetti A, et al. Neglected lead tip erosion: an unusual case of S-ICD inappropriate shock. J Cardiovasc Electrophysiol. 2020 Dec;31(12):3322–3325.